PLEASE NOTE: WE ARE NO LONGER ACCEPTING REGISTRATIONS FOR THIS FULLY-BOOKED EVENT.
Please contact: firstname.lastname@example.org if you have questions regarding this.
Our 10th annual seminar will focus on Precision Treatment: Exploiting Recent Advances – Fast and Furious?
Cancer Crosslinks 2018 includes a daytime program from 9am-4pm, and an evening reception beginning at 6:30pm.
Daytime Program: 9am-4pm at Oslo Cancer Cluster Innovation Park
Join our distinguished panel of international and Norwegian experts as they take a closer look at Precision Treatment. Topics include:
- Cancer Immunotherapy – The Journey So Far and Where We are Heading
Jeffrey S. Weber, Professor, Deputy Director and Co-Director, Melanoma Program, Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, USA
- The Microbiome, Cancer and Cachexia
Laure Bindels, Louvain Drug Research Institute, Université catholique de Louvain, Belgium
- From Feasibility to Utility in Precision Cancer Medicine – Experiences from the First Norwegian Study of NGS-Based Therapy Decisions in Advanced Cancer
Hege G. Russnes, Senior Consultant and Researcher, Oslo University Hospital, Norwegian Radium Hospital, Norway
Anne Hansen Ree, Professor, Akershus University Hospital, University of Oslo, Norway
- Precision Medicine for Gynecologic Cancers – Opportunities and Obstacles
Douglas A. Levine, Professor, Director of Gynecologic Oncology, Laura and Isaac Perlmutter Cancer Center & Head, Gynecology Research Laboratory, NYU Langone Medical Center, New York, USA
- Roadmap for European Hematology Research and Hodgkin Lymphoma: (Immuno)therapy, Late Effects and the Way Forward
Andreas Engert, Professor for Internal Medicine, Hematology and Oncology, University Hospital of Cologne, Germany
- The Next Generation of Engineered T-cells for Immunotherapy of Hematological and Solid Tumors
Marcela V. Maus, Assistant Professor, Harvard Medical School & Director of Cellular Immunotherapy, Cancer Center, Massachusetts General Hospital, Boston, USA
- Making Sense of Big Data for Oncology Patients – Vision and Reality
Marc Vaudel, Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital and KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Norway
Elisabeth Wik, Centre for Cancer Biomarkers, University of Bergen and Deparment of Pathology, Haukeland University Hospital, Norway
Cancer Crosslinks 2018 will gather experts in oncology research to discuss new perspectives, and the challenges and opportunities ahead when translating new insights into better treatments for cancer patients.
Evening Program: Reception begins at 6:30pm at Rodins Bistro, Karl Johans gate 12 (Oslo Sentrum)
Please find the program HERE